Badat, Mohsin
Ejaz, Ayesha
Hua, Peng http://orcid.org/0000-0003-3774-5033
Rice, Siobhan
Zhang, Weijiao
Hentges, Lance D. http://orcid.org/0000-0001-6327-6774
Fisher, Christopher A.
Denny, Nicholas http://orcid.org/0000-0002-5351-9581
Schwessinger, Ron
Yasara, Nirmani http://orcid.org/0000-0002-1480-4849
Roy, Noemi B. A.
Issa, Fadi http://orcid.org/0000-0002-8279-7732
Roy, Andi http://orcid.org/0000-0001-8607-5748
Telfer, Paul
Hughes, Jim http://orcid.org/0000-0002-8955-7256
Mettananda, Sachith
Higgs, Douglas R. http://orcid.org/0000-0003-3579-8705
Davies, James O. J. http://orcid.org/0000-0002-4108-4357
Funding for this research was provided by:
RCUK | Medical Research Council (MC_PC_15069, MC_UU_00029/04)
DH | NIHR | Health Services Research Programme (NIHR203339, NIHR203311)
Wellcome Trust (225220/Z/22/Z, 102176/B/13/Z, 211122/Z/18, 225220/Z/22/Z)
RCUK | MRC | Medical Research Foundation (MR/P019633/1, MR/R008108, MR/T030410/1, MC_UU_00016/14)
DH | National Institute for Health Research (NIHR203311)
Article History
Received: 4 July 2022
Accepted: 23 March 2023
First Online: 19 April 2023
Competing interests
: J.D., M.B. and D.H. have filed a patent application on this work,<sup>24</sup> which has been licensed to BEAM therapeutics. J.D. and M.B. receive revenue from this licence and hold personal shares in BEAM therapeutics. J.D. and J.H. are co-founders of Nucleome Therapeutics Ltd. and provide consultancy to the company. The remaining authors declare no competing interests.